Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 90pembrolizumab 73Pemetrexed 66Cisplatin 56atezolizumab 31Paclitaxel 31Docetaxel 30durvalumab 28Specimen Handling 26Nivolumab 26Magnetic Resonance Spectroscopy 21osimertinib 20Gemcitabine 19130-nm albumin-bound paclitaxel 18Etoposide 17Cetuximab 16Radiotherapy 14Platinum 131,2-diaminocyclohexaneplatinum II citrate 11amivantamab 10Taxes 10Immunoglobulin G 10Radiation 9PM 01183 9Ipilimumab 9Disulfides 9Bevacizumab 9Topotecan 8lazertinib 7fludarabine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Doxycycline × Thoracic × 30 days × Clear all
NCT06120140 2026-06-05

COCOON

Janssen Research & Development, LLC

Phase 2 Active not recruiting
305 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡